BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Matsuda M. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma. World J Hepatol 2015; 7(30): 2933-2939 [PMID: 26730272 DOI: 10.4254/wjh.v7.i30.2933]
URL: https://www.wjgnet.com/1948-5182/full/v7/i30/2933.htm
Number Citing Articles
1
B.G. Tillman, J.D. Gorman, J.M. Hru, M.H. Lee, M.C. King, C.B. Sirlin, R.M. Marks. Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screeningClinical Radiology 2018; 73(5): 485 doi: 10.1016/j.crad.2017.11.013
2
Yoshiteru Hao, Kazushi Numata, Tomohiro Ishii, Hiroyuki Fukuda, Shin Maeda, Masayuki Nakano, Katsuaki Tanaka. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(17): 3111-3121 doi: 10.3748/wjg.v23.i17.3111
3
Masanori Matsuda. 10. Surgical Treatment of Hepatocellular CarcinomaJapanese Journal of Radiological Technology 2017; 73(4): 319 doi: 10.6009/jjrt.2017_JSRT_73.4.319